321 related articles for article (PubMed ID: 34437568)
1. Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients.
Palmas F; Clarke J; Colas RA; Gomez EA; Keogh A; Boylan M; McEvoy N; McElvaney OJ; McElvaney O; Alalqam R; McElvaney NG; Curley GF; Dalli J
PLoS One; 2021; 16(8):e0256226. PubMed ID: 34437568
[TBL] [Abstract][Full Text] [Related]
2. Acute severe SARS COVID-19 patients produce pro-resolving lipids mediators and eicosanoids.
Regidor PA; De La Rosa X; Santos FG; Rizo JM; Gracia Banzo R; Silva RS
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6782-6796. PubMed ID: 34787883
[TBL] [Abstract][Full Text] [Related]
3. Bad Prognosis in Critical Ill Patients with COVID-19 during Short-Term ICU Stay regarding Vitamin D Levels.
Herrera-Quintana L; Gamarra-Morales Y; Vázquez-Lorente H; Molina-López J; Castaño-Pérez J; Machado-Casas JF; Coca-Zúñiga R; Pérez-Villares JM; Planells E
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34207873
[TBL] [Abstract][Full Text] [Related]
4. Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis.
Tepasse PR; Vollenberg R; Fobker M; Kabar I; Schmidt H; Meier JA; Nowacki T; Hüsing-Kabar A
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34202697
[TBL] [Abstract][Full Text] [Related]
5. Profiling of inflammatory biomarkers in mild to critically ill severe acute respiratory syndrome corona virus-19 (SARS Covid-19) patients from Karachi, Pakistan.
Alam JM; Asghar SS; Ali H; Mahmood SR; Ansari MA
Pak J Pharm Sci; 2021 Jan; 34(1(Special)):429-433. PubMed ID: 34275790
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID-19.
Myhre PL; Prebensen C; Jonassen CM; Berdal JE; Omland T
J Am Heart Assoc; 2021 May; 10(9):e019756. PubMed ID: 33596668
[TBL] [Abstract][Full Text] [Related]
7. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.
Bermejo-Martin JF; González-Rivera M; Almansa R; Micheloud D; Tedim AP; Domínguez-Gil M; Resino S; Martín-Fernández M; Ryan Murua P; Pérez-García F; Tamayo L; Lopez-Izquierdo R; Bustamante E; Aldecoa C; Gómez JM; Rico-Feijoo J; Orduña A; Méndez R; Fernández Natal I; Megías G; González-Estecha M; Carriedo D; Doncel C; Jorge N; Ortega A; de la Fuente A; Del Campo F; Fernández-Ratero JA; Trapiello W; González-Jiménez P; Ruiz G; Kelvin AA; Ostadgavahi AT; Oneizat R; Ruiz LM; Miguéns I; Gargallo E; Muñoz I; Pelegrin S; Martín S; García Olivares P; Cedeño JA; Ruiz Albi T; Puertas C; Berezo JÁ; Renedo G; Herrán R; Bustamante-Munguira J; Enríquez P; Cicuendez R; Blanco J; Abadia J; Gómez Barquero J; Mamolar N; Blanca-López N; Valdivia LJ; Fernández Caso B; Mantecón MÁ; Motos A; Fernandez-Barat L; Ferrer R; Barbé F; Torres A; Menéndez R; Eiros JM; Kelvin DJ
Crit Care; 2020 Dec; 24(1):691. PubMed ID: 33317616
[TBL] [Abstract][Full Text] [Related]
8. Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19.
de Nooijer AH; Grondman I; Lambden S; Kooistra EJ; Janssen NAF; Kox M; Pickkers P; Joosten LAB; van de Veerdonk FL; Derive M; Gibot S; Netea MG;
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34195785
[TBL] [Abstract][Full Text] [Related]
9. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and risk factors for severe-critically ill COVID-19 adult patients in Jiangsu, China: A multiple-centered, retrospective study.
Zhao J; Zhu M; Su X; Huang M; Yang Y; Huang J; Songshi N; Cao Q; Gu Q; Li J; Li J; Zhao W; Shi B; Shi Y
Medicine (Baltimore); 2021 Feb; 100(5):e24332. PubMed ID: 33592878
[TBL] [Abstract][Full Text] [Related]
11. The effect of age on the clinical and immune characteristics of critically ill patients with COVID-19: A preliminary report.
Hu C; Li J; Xing X; Gao J; Zhao S; Xing L
PLoS One; 2021; 16(3):e0248675. PubMed ID: 33735325
[TBL] [Abstract][Full Text] [Related]
12. Human Sepsis Eicosanoid and Proresolving Lipid Mediator Temporal Profiles: Correlations With Survival and Clinical Outcomes.
Dalli J; Colas RA; Quintana C; Barragan-Bradford D; Hurwitz S; Levy BD; Choi AM; Serhan CN; Baron RM
Crit Care Med; 2017 Jan; 45(1):58-68. PubMed ID: 27632672
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Antithrombin Levels in COVID-19 Patients and Impact of Fresh Frozen Plasma Treatment: A Retrospective Study.
Anaklı İ; Ergin Özcan P; Polat Ö; Orhun G; Alay GH; Tuna V; Çeliksoy E; Kılıç M; Mercan M; Ali A; Beşışık S; Esen F
Turk J Haematol; 2021 Feb; 38(1):15-21. PubMed ID: 33486940
[TBL] [Abstract][Full Text] [Related]
14. The value of lymphocyte count in determining the severity of COVID-19 and estimating the time for nucleic acid test results to turn negative.
Li Y; Yang T; Wang S; Zheng J; Zhou J; Jiang M; Zhou T; Cao Y; Wang H
Bosn J Basic Med Sci; 2021 Apr; 21(2):235-241. PubMed ID: 32893759
[TBL] [Abstract][Full Text] [Related]
15. A survey on acute kidney injury in severely and critically ill COVID-19 patients without chronic kidney disease.
Yu Y; Ge H; Wang X; Huang Z; Chen L; Han Y; Jiang D; Tao L; Zhou Q; Peng Z; Xiao X
Ann Palliat Med; 2021 Jun; 10(6):6198-6207. PubMed ID: 34044555
[TBL] [Abstract][Full Text] [Related]
16. No detection of SARS-CoV-2 from urine, expressed prostatic secretions, and semen in 74 recovered COVID-19 male patients: A perspective and urogenital evaluation.
Ruan Y; Hu B; Liu Z; Liu K; Jiang H; Li H; Li R; Luan Y; Liu X; Yu G; Xu S; Yuan X; Wang S; Yang W; Ye Z; Liu J; Wang T
Andrology; 2021 Jan; 9(1):99-106. PubMed ID: 33150723
[TBL] [Abstract][Full Text] [Related]
17. High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.
Ouwendijk WJD; Raadsen MP; van Kampen JJA; Verdijk RM; von der Thusen JH; Guo L; Hoek RAS; van den Akker JPC; Endeman H; Langerak T; Molenkamp R; Gommers D; Koopmans MPG; van Gorp ECM; Verjans GMGM; Haagmans BL
J Infect Dis; 2021 May; 223(9):1512-1521. PubMed ID: 33507309
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of viral load and antibody response in relation to COVID-19 severity.
Wang Y; Zhang L; Sang L; Ye F; Ruan S; Zhong B; Song T; Alshukairi AN; Chen R; Zhang Z; Gan M; Zhu A; Huang Y; Luo L; Mok CKP; Al Gethamy MM; Tan H; Li Z; Huang X; Li F; Sun J; Zhang Y; Wen L; Li Y; Chen Z; Zhuang Z; Zhuo J; Chen C; Kuang L; Wang J; Lv H; Jiang Y; Li M; Lin Y; Deng Y; Tang L; Liang J; Huang J; Perlman S; Zhong N; Zhao J; Malik Peiris JS; Li Y; Zhao J
J Clin Invest; 2020 Oct; 130(10):5235-5244. PubMed ID: 32634129
[TBL] [Abstract][Full Text] [Related]
19. Rhabdomyolysis in Severe COVID-19: Male Sex, High Body Mass Index, and Prone Positioning Confer High Risk.
Mokhtari AK; Maurer LR; Christensen MA; Moheb ME; Naar L; Alser O; Gaitanidis A; Langeveld K; Kapoen C; Breen K; Velmahos GC; Kaafarani HMA
J Surg Res; 2021 Oct; 266():35-43. PubMed ID: 33975028
[TBL] [Abstract][Full Text] [Related]
20. Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study.
Irún P; Gracia R; Piazuelo E; Pardo J; Morte E; Paño JR; Boza J; Carrera-Lasfuentes P; Higuera GA; Lanas A
Sci Rep; 2023 Apr; 13(1):6497. PubMed ID: 37081104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
